[1] PubMed ID: | 36973570 |
Disease Name: | Carcinoma, Hepatocellular |
Tissue: | Liver |
Dysfunction Pattern: | Down-Regulation |
Validated Method: | PCR//Western blot//Northern blot//High-throughput sequencing |
Description: | A novel tsRNA, tRNAGln-TTG derived 5′-tiRNA-Gln, is significantly downregulated, and its expression level is correlated with progression in patients. |
Comparision: | HCC VS Normal |
Mechanism: | 5′-tiRNA-Gln exerted its function by binding eukaryotic initiation factor 4A-I (EIF4A1), which unwinds complex RNA secondary structures during translation initiation, causing the partial inhibition of translation. The suppressed downregulated proteins include ARAF, MEK1/2 and STAT3, causing the impaired signaling pathway related to HCC progression. Furthermore, based on the construction of a mutant 5′-tiRNA-Gln, the sequence of forming intramolecular G-quadruplex structure is crucial for 5′-tiRNA-Gln to strongly bind EIF4A1 and repress translation. |
|